Futura Medical (GB:FUM) has released an update.
Futura Medical plc, a consumer healthcare company known for its sexual health products, will release its financial results for the first half of 2024 on September 10. They will also host webinars for retail investors and analysts to discuss the results and engage with management. The company, which specializes in topical treatments like the fast-acting ED gel Eroxon, continues to address unmet needs in the sexual health market.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
